Abstract
Obesity has been linked to immunosuppressive effects and increased susceptibility to respiratory infections, including COVID-19. Bariatric surgery (BS) has demonstrated promising results in enhancing a variety of clinical outcomes in obese patients. The purpose of this meta-analysis is to evaluate the effect of BS on COVID-19 outcomes, specifically all-cause mortality. A thorough literature search was conducted in electronic databases to identify pertinent studies through November 2022. Inclusion criteria included retrospective cohort studies that investigated the association between BS and COVID-19 mortality. Data extraction and quality assessment were carried out in accordance with established protocols. A random-effects model was used to calculate the odds ratio (OR) and 95% confidence intervals (CIs). Using I2 statistics, heterogeneity was evaluated, and publication bias was assessed using funnel plots. Eight retrospective studies involving a total cohort of 409,665 patients met the quantitative analysis eligibility criteria. In the crude unmatched analysis, the overall mortality rate among patients with prior BS was significantly lower than among those without BS (OR 0.52; 95% CI [0.43, 0.62]; p = 0.03; I2 = 53.66%). After adjusting for comorbidities, the matched analysis yielded comparable results (OR 0.42, 95% CI [0.25, 0.72], p = 0.14, I2 = 41.88%). Comparing the BS group to the non-BS group, subgroup analyses by country (the USA and Europe) showed that the BS group had a mortality risk that was nearly 50% lower. The funnel plot indicated that there was no publication bias, and the sensitivity analysis revealed balanced results when each study was excluded. This meta-analysis suggests that a history of BS is associated with a decreased risk of deaths from all causes in COVID-19 patients. These results highlight the prospective benefits of BS in mitigating adverse outcomes in obese COVID-19 patients. To investigate the underlying mechanisms and potential confounders of this association, additional research is required.
Similar content being viewed by others
Data Availability
All data generated or analyzed during this study are included in this published article.
Code Availability
Not applicable.
Abbreviations
- BS :
-
Bariatric surgery
- OR :
-
Odds ratio
References
Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012;71(2):298–306. https://doi.org/10.1017/S0029665112000158.
Dixon AE, Peters U. The effect of obesity on lung function. Exp Rev Respir Med. 2018;12(9):755–67. https://doi.org/10.1080/17476348.2018.1506331.
Xiang M, Wu X, Jing H, Novakovic VA, Shi J. The intersection of obesity and (long) COVID-19: hypoxia, thrombotic inflammation, and vascular endothelial injury. Front Cardiovasc Med. 2023;10:1062491. https://doi.org/10.3389/fcvm.2023.1062491.
Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: a systematic review and meta-analysis. J Med Virol. 2021;93(1):257–61. https://doi.org/10.1002/jmv.26237.
Hung KC, Chen HT, Hsing CH, et al. Impact of prior bariatric surgery on risk and severity of COVID-19 infection: a meta-analysis of observational studies. Obes Res Clin Pract. 2022;16(6):439–46. https://doi.org/10.1016/j.orcp.2022.10.005.
Cai Z, Zhong J, Jiang Y, Zhang J. Bariatric surgery and COVID-19 outcomes: a systematic review and meta-analysis. Surg Obes Relat Dis. 2023;19(9):1058–66. https://doi.org/10.1016/j.soard.2023.02.023.
Hasnain N, Moeed A, Waqar E, Farhan SA, Amreek F. Efficacy of bariatric surgery in COVID-19 patients: an updated systematic review and meta-analysis. Surg Pract Sci. 2022;11:100140. https://doi.org/10.1016/j.sipas.2022.100140.
Nieman DC, Henson DA, Nehlsen-Cannarella SL, et al. Influence of obesity on immune function. J Am Diet Assoc. 1999;99(3):294–9. https://doi.org/10.1016/s0002-8223(99)00077-2.
Guo SA, Bowyer GS, Ferdinand JR, et al. Obesity is associated with attenuated tissue immunity in COVID-19. Am J Respir Crit Care Med. 2023;207(5):566–76. https://doi.org/10.1164/rccm.202204-0751OC.
Obesity is associated with severe forms of COVID-19. Obesity (Silver Spring). 2020;28(10):1993. https://doi.org/10.1002/oby.22998.
Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships [published correction appears in Obes Rev. Obes Rev. 2020;21(11):e13128. https://doi.org/10.1111/obr.13128.
Chen G, Mainous A, Ayzengart A, Hong Y-R. Association between bariatric surgery and severe COVID-19 outcomes in Florida. Obes Surg. 2022;32(11):3807–10. https://doi.org/10.1007/s11695-022-06281-9.
Iannelli A, Bouam S, Schneck A-S, et al. The impact of previous history of bariatric surgery on outcome of COVID-19. A nationwide medico-administrative French study. Obes Surg. 2021;31(4):1455–63. https://doi.org/10.1007/s11695-020-05120-z.
Aminian A, Fathalizadeh A, Tu C, et al. Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity. Surg Obes Relat Dis. 2021;17(1):208–14. https://doi.org/10.1016/j.soard.2020.10.026.
Purdy AC, Hohmann SF, Nguyen NT. Outcomes of obese patients hospitalized with COVID-19: the impact of prior bariatric surgery. Surg Obes Relat Dis. 2022;18(1):35–40. https://doi.org/10.1016/j.soard.2021.08.027.
Hadi YB, Mann R, Sohail AH, et al. Prior bariatric surgery is associated with a reduced risk of poor outcomes in COVID-19: propensity matched analysis of a large multi-institutional research network. Obes Surg. 2022;32(2):237–44. https://doi.org/10.1007/s11695-021-05803-1.
Marchesi F, Valente M, Riccò M, et al. Effects of bariatric surgery on COVID-19: a multicentric study from a high incidence area. Obes Surg. 2021;31(6):2477–88. https://doi.org/10.1007/s11695-020-05193-w.
Blanchard C, Perennec T, Smati S, et al. History of bariatric surgery and COVID-19 outcomes in patients with type 2 diabetes: results from the CORONADO study. Obesity (Silver Spring). 2022;30(3):599–605. https://doi.org/10.1002/oby.23314.
Aminian A, Tu C, Milinovich A, Wolski KE, Kattan MW, Nissen SE. Association of weight loss achieved through metabolic surgery with risk and severity of COVID-19 infection. JAMA Surgery. 2022;157(3):221–30. https://doi.org/10.1001/jamasurg.2021.6496.
Jenkins M, Maranga G, Wood GC, Petrilli CM, Fielding G, Ren-Fielding C. Prior bariatric surgery in COVID-19-positive patients may be protective. Surg Obes Relat Dis. 2021;17(11):1840–5. https://doi.org/10.1016/j.soard.2021.07.024.
Author information
Authors and Affiliations
Contributions
AB: resources, investigation writing - original draft; visualization, writing - review and editing, investigation, formal analysis
MK: methodology, writing, original draft; writing - review and editing, visualization, investigation
SRS: writing - original draft; writing - review and editing, investigation, visualization
ATA: writing - original draft; writing - review and editing, investigation, visualization
AP: writing - original draft; writing - review and editing, investigation, visualization
AP: writing - original draft; writing - review and editing, investigation, visualization
BT: writing - original draft; writing - review and editing, investigation, visualization
SAR: writing - original draft; writing - review and editing, investigation, visualization
SC: conceptualization, methodology, writing - original draft, writing - review and editing, visualization, supervision
RD: conceptualization, methodology, software, formal analysis, resources, writing original draft; writing - review and editing, administration, supervision
All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Since the data included in this review were deidentified and already available in publicly accessible databases, the IRB review was not mandatory. This review was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Study Highlights
• Bariatric surgery (BS) is associated with a significantly lower risk (OR 0.52) of all-cause mortality in COVID-19 patients.
• The meta-analysis includes data from eight studies involving 409,665 patients, providing robust statistical power.
• BS shows consistent mortality risk reduction in both the USA and Europe.
• No publication bias was detected, and results remain stable in sensitivity analysis.
• BS offers potential benefits in reducing adverse outcomes for obese COVID-19 patients, warranting further investigation.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bhanushali, A., Kohli, M., Sarvepalli, S.R. et al. Impact of Prior Bariatric Surgery on Mortality in COVID-19 Patients: a Comprehensive Meta-analysis. SN Compr. Clin. Med. 6, 8 (2024). https://doi.org/10.1007/s42399-023-01633-7
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-023-01633-7